150483 20260411074140.0 doi 10.1111/ijd.17569 sideral 142684 ART-2025-142684 eng (orcid)0000-0001-5632-0351 Marron, Servando E. Universidad de Zaragoza Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe 2025 IntroductionHidradenitis suppurativa (HS) can severely affect the quality of life (QoL) and is linked to psychological distress, including anxiety, depression, and reduced self‐esteem. Stigmatization due to physical appearance may significantly contribute to the psychological burden and impact on QoL for HS patients. This study investigates the association between stigmatization, depression, anxiety, and health‐ and disease‐related variables among HS patients in Europe.Patients and methodsThis observational cross‐sectional multicenter study was conducted across 22 dermatological outpatient clinics in 17 European countries. Data collected included sociodemographic variables, general health variables, disease‐related variables, perceived stigmatization (PSQ), and mental health (PHQ‐2, GAD‐2).ResultsOf the 5487 dermatological patients, 142 (2.6%) were diagnosed with HS, and data from 135 patients (70.1% women, mean age 38.2 years) who completed the PSQ questionnaire were analyzed. Scores on the stigmatization measure indicated that significant stigmatization levels were present in the sample. Linear regression models revealed a significant relationship between stigmatization and both the duration of HS and the presence of itch. Similar findings were noted for the PSQ “confused/staring behavior” scale with depression. The PSQ “absence of friendly behavior” scale was inversely associated with general health status, whereas the “hostile behavior” scale was positively linked to depression.ConclusionHS patients experience significant stigmatization linked to disease duration, itch, and depression. Comprehensive management, including screening for psychosocial co‐morbidity, is essential, as is providing access to psychological interventions that support patients to both manage internal distress and the potential reactions of others. info:eu-repo/semantics/openAccess All rights reserved http://www.europeana.eu/rights/rr-f/ 3.3 2024 DERMATOLOGY 23 / 96 = 0.24 2024 Q1 T1 0.822 2024 Dermatology 2024 Q1 4.5 2024 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Gracia-Cazaña, Tamara Universidad de Zaragoza Sampogna, Francesca Schut, Christina Kupfer, Joerg Dalgard, Florence J. Bewley, Anthony van Beugen, Sylvia Gieler, Uwe Lien, Lars Ständer, Sonja Vulink, Nienke Finlay, Andrew Y. Legat, Franz J. Titeca, Geraldine Jemec, Gregor B. Misery, Laurent Szabo, Csanad Grivcheva-Panovska, Vesna Spillekom-van Koulil, Saskia Balieva, Flora Szepietowski, Jacek C. Reich, Adam Roque Ferreira, Bárbara Lvov, Andrey Romanov, Dmitry Svensson, Ake Altunay, Ilknur K. Thompson, Andrew R. Zeidler, Claudia Tomas-Aragones, Lucía (orcid)0000-0003-1917-6906 1007 183 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Área Dermatología 64, 5 (2025), 861-869 Int. j. dermatol. INTERNATIONAL JOURNAL OF DERMATOLOGY 0011-9059 427239 http://zaguan.unizar.es/record/150483/files/texto_completo.pdf Versión publicada info:eu-repo/date/embargoEnd/2025-11-11 2382031 http://zaguan.unizar.es/record/150483/files/texto_completo.jpg?subformat=icon icon Versión publicada info:eu-repo/date/embargoEnd/2025-11-11 oai:zaguan.unizar.es:150483 articulos driver 2026-04-10-13:53:48 ARTICLE